Global Foot and Mouth Disease (FMD) Vaccines Market Insights, Forecast to 2026

Global Foot and Mouth Disease (FMD) Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Foot and Mouth Disease (FMD) Vaccines Product Introduction
1.2 Market Segments
1.3 Key Foot and Mouth Disease (FMD) Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type
1.4.2 Emergency Vaccines
1.4.3 Conventional Vaccines
1.5 Market by Application
1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application
1.5.2 Cattle
1.5.3 Pig
1.5.4 Sheep & Goat
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Foot and Mouth Disease (FMD) Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Foot and Mouth Disease (FMD) Vaccines Industry
1.6.1.1 Foot and Mouth Disease (FMD) Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Foot and Mouth Disease (FMD) Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Foot and Mouth Disease (FMD) Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts
2.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2015-2026
2.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2015-2026
2.2 Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Foot and Mouth Disease (FMD) Vaccines Competitor Landscape by Players
3.1 Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers
3.1.1 Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers
3.2.1 Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccines Revenue in 2019
3.2.5 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Foot and Mouth Disease (FMD) Vaccines Price by Manufacturers
3.4 Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Foot and Mouth Disease (FMD) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Type (2015-2020)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2015-2020)
4.1.3 Foot and Mouth Disease (FMD) Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Foot and Mouth Disease (FMD) Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Application (2015-2020)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2015-2020)
5.1.3 Foot and Mouth Disease (FMD) Vaccines Price by Application (2015-2020)
5.2 Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Foot and Mouth Disease (FMD) Vaccines by Country
6.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country
6.1.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Type
6.3 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Foot and Mouth Disease (FMD) Vaccines by Country
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Type
7.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines by Region
8.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region
8.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Foot and Mouth Disease (FMD) Vaccines by Country
9.1.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country
9.1.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Type
9.3 Central & South America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines by Country
10.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country
10.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Description, Business Overview and Total Revenue
11.1.3 Jinyu Group Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Products Offered
11.1.5 Jinyu Group Recent Development
11.2 Cavet Bio
11.2.1 Cavet Bio Corporation Information
11.2.2 Cavet Bio Description, Business Overview and Total Revenue
11.2.3 Cavet Bio Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Products Offered
11.2.5 Cavet Bio Recent Development
11.3 Indian Immunologicals
11.3.1 Indian Immunologicals Corporation Information
11.3.2 Indian Immunologicals Description, Business Overview and Total Revenue
11.3.3 Indian Immunologicals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Products Offered
11.3.5 Indian Immunologicals Recent Development
11.4 Tecon Group
11.4.1 Tecon Group Corporation Information
11.4.2 Tecon Group Description, Business Overview and Total Revenue
11.4.3 Tecon Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Products Offered
11.4.5 Tecon Group Recent Development
11.5 CAHIC
11.5.1 CAHIC Corporation Information
11.5.2 CAHIC Description, Business Overview and Total Revenue
11.5.3 CAHIC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Products Offered
11.5.5 CAHIC Recent Development
11.6 Shen Lian
11.6.1 Shen Lian Corporation Information
11.6.2 Shen Lian Description, Business Overview and Total Revenue
11.6.3 Shen Lian Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Products Offered
11.6.5 Shen Lian Recent Development
11.7 Biogenesis Bagó
11.7.1 Biogenesis Bagó Corporation Information
11.7.2 Biogenesis Bagó Description, Business Overview and Total Revenue
11.7.3 Biogenesis Bagó Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Products Offered
11.7.5 Biogenesis Bagó Recent Development
11.8 BIGVET Biotech
11.8.1 BIGVET Biotech Corporation Information
11.8.2 BIGVET Biotech Description, Business Overview and Total Revenue
11.8.3 BIGVET Biotech Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Products Offered
11.8.5 BIGVET Biotech Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 MSD Animal Health
11.10.1 MSD Animal Health Corporation Information
11.10.2 MSD Animal Health Description, Business Overview and Total Revenue
11.10.3 MSD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Products Offered
11.10.5 MSD Animal Health Recent Development
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Description, Business Overview and Total Revenue
11.1.3 Jinyu Group Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Products Offered
11.1.5 Jinyu Group Recent Development
11.12 FGBI
11.12.1 FGBI Corporation Information
11.12.2 FGBI Description, Business Overview and Total Revenue
11.12.3 FGBI Sales, Revenue and Gross Margin (2015-2020)
11.12.4 FGBI Products Offered
11.12.5 FGBI Recent Development
11.13 Bayer HealthCare
11.13.1 Bayer HealthCare Corporation Information
11.13.2 Bayer HealthCare Description, Business Overview and Total Revenue
11.13.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bayer HealthCare Products Offered
11.13.5 Bayer HealthCare Recent Development
11.14 Brilliant Bio Pharma
11.14.1 Brilliant Bio Pharma Corporation Information
11.14.2 Brilliant Bio Pharma Description, Business Overview and Total Revenue
11.14.3 Brilliant Bio Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Brilliant Bio Pharma Products Offered
11.14.5 Brilliant Bio Pharma Recent Development
11.15 VECOL
11.15.1 VECOL Corporation Information
11.15.2 VECOL Description, Business Overview and Total Revenue
11.15.3 VECOL Sales, Revenue and Gross Margin (2015-2020)
11.15.4 VECOL Products Offered
11.15.5 VECOL Recent Development
11.16 Sanofi (Merial)
11.16.1 Sanofi (Merial) Corporation Information
11.16.2 Sanofi (Merial) Description, Business Overview and Total Revenue
11.16.3 Sanofi (Merial) Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sanofi (Merial) Products Offered
11.16.5 Sanofi (Merial) Recent Development
11.17 VETAL
11.17.1 VETAL Corporation Information
11.17.2 VETAL Description, Business Overview and Total Revenue
11.17.3 VETAL Sales, Revenue and Gross Margin (2015-2020)
11.17.4 VETAL Products Offered
11.17.5 VETAL Recent Development
11.18 BVI
11.18.1 BVI Corporation Information
11.18.2 BVI Description, Business Overview and Total Revenue
11.18.3 BVI Sales, Revenue and Gross Margin (2015-2020)
11.18.4 BVI Products Offered
11.18.5 BVI Recent Development
11.19 LIMOR
11.19.1 LIMOR Corporation Information
11.19.2 LIMOR Description, Business Overview and Total Revenue
11.19.3 LIMOR Sales, Revenue and Gross Margin (2015-2020)
11.19.4 LIMOR Products Offered
11.19.5 LIMOR Recent Development
11.20 ME VAC
11.20.1 ME VAC Corporation Information
11.20.2 ME VAC Description, Business Overview and Total Revenue
11.20.3 ME VAC Sales, Revenue and Gross Margin (2015-2020)
11.20.4 ME VAC Products Offered
11.20.5 ME VAC Recent Development
11.21 Agrovet
11.21.1 Agrovet Corporation Information
11.21.2 Agrovet Description, Business Overview and Total Revenue
11.21.3 Agrovet Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Agrovet Products Offered
11.21.5 Agrovet Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Region
12.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Foot and Mouth Disease (FMD) Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Foot and Mouth Disease (FMD) Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Foot and Mouth Disease (FMD) Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Foot and Mouth Disease (FMD) Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Foot and Mouth Disease (FMD) Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Foot and Mouth Disease (FMD) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Foot and Mouth Disease (FMD) Vaccines Market Segments
Table 2. Ranking of Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Emergency Vaccines
Table 5. Major Manufacturers of Conventional Vaccines
Table 6. COVID-19 Impact Global Market: (Four Foot and Mouth Disease (FMD) Vaccines Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Foot and Mouth Disease (FMD) Vaccines Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Foot and Mouth Disease (FMD) Vaccines Players to Combat Covid-19 Impact
Table 11. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application 2020-2026 (K L)
Table 12. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 13. Global Foot and Mouth Disease (FMD) Vaccines Sales by Regions 2015-2020 (K L)
Table 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Regions (2015-2020)
Table 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2015-2020) (K L)
Table 17. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers (2015-2020)
Table 18. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2019)
Table 20. Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Price (2015-2020) (USD/L)
Table 23. Foot and Mouth Disease (FMD) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
Table 25. Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2015-2020)
Table 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2015-2020)
Table 31. Foot and Mouth Disease (FMD) Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 32. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 33. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2015-2020)
Table 34. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2015-2020) (K L)
Table 35. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2015-2020)
Table 36. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2015-2020)
Table 38. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 39. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 40. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 41. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 42. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2015-2020) (K L)
Table 43. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2015-2020)
Table 44. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2015-2020)
Table 46. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 47. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 48. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 49. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2015-2020) (K L)
Table 51. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 55. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 57. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 58. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2015-2020) (K L)
Table 59. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 63. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 64. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 65. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2015-2020) (K L)
Table 67. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2015-2020) (K L)
Table 71. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2015-2020) (K L)
Table 73. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 74. Jinyu Group Corporation Information
Table 75. Jinyu Group Description and Major Businesses
Table 76. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 77. Jinyu Group Product
Table 78. Jinyu Group Recent Development
Table 79. Cavet Bio Corporation Information
Table 80. Cavet Bio Description and Major Businesses
Table 81. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 82. Cavet Bio Product
Table 83. Cavet Bio Recent Development
Table 84. Indian Immunologicals Corporation Information
Table 85. Indian Immunologicals Description and Major Businesses
Table 86. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 87. Indian Immunologicals Product
Table 88. Indian Immunologicals Recent Development
Table 89. Tecon Group Corporation Information
Table 90. Tecon Group Description and Major Businesses
Table 91. Tecon Group Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 92. Tecon Group Product
Table 93. Tecon Group Recent Development
Table 94. CAHIC Corporation Information
Table 95. CAHIC Description and Major Businesses
Table 96. CAHIC Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 97. CAHIC Product
Table 98. CAHIC Recent Development
Table 99. Shen Lian Corporation Information
Table 100. Shen Lian Description and Major Businesses
Table 101. Shen Lian Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 102. Shen Lian Product
Table 103. Shen Lian Recent Development
Table 104. Biogenesis Bagó Corporation Information
Table 105. Biogenesis Bagó Description and Major Businesses
Table 106. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 107. Biogenesis Bagó Product
Table 108. Biogenesis Bagó Recent Development
Table 109. BIGVET Biotech Corporation Information
Table 110. BIGVET Biotech Description and Major Businesses
Table 111. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 112. BIGVET Biotech Product
Table 113. BIGVET Biotech Recent Development
Table 114. Boehringer Ingelheim Corporation Information
Table 115. Boehringer Ingelheim Description and Major Businesses
Table 116. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Boehringer Ingelheim Product
Table 118. Boehringer Ingelheim Recent Development
Table 119. MSD Animal Health Corporation Information
Table 120. MSD Animal Health Description and Major Businesses
Table 121. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 122. MSD Animal Health Product
Table 123. MSD Animal Health Recent Development
Table 124. CEVA Corporation Information
Table 125. CEVA Description and Major Businesses
Table 126. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 127. CEVA Product
Table 128. CEVA Recent Development
Table 129. FGBI Corporation Information
Table 130. FGBI Description and Major Businesses
Table 131. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 132. FGBI Product
Table 133. FGBI Recent Development
Table 134. Bayer HealthCare Corporation Information
Table 135. Bayer HealthCare Description and Major Businesses
Table 136. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 137. Bayer HealthCare Product
Table 138. Bayer HealthCare Recent Development
Table 139. Brilliant Bio Pharma Corporation Information
Table 140. Brilliant Bio Pharma Description and Major Businesses
Table 141. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 142. Brilliant Bio Pharma Product
Table 143. Brilliant Bio Pharma Recent Development
Table 144. VECOL Corporation Information
Table 145. VECOL Description and Major Businesses
Table 146. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 147. VECOL Product
Table 148. VECOL Recent Development
Table 149. Sanofi (Merial) Corporation Information
Table 150. Sanofi (Merial) Description and Major Businesses
Table 151. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 152. Sanofi (Merial) Product
Table 153. Sanofi (Merial) Recent Development
Table 154. VETAL Corporation Information
Table 155. VETAL Description and Major Businesses
Table 156. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 157. VETAL Product
Table 158. VETAL Recent Development
Table 159. BVI Corporation Information
Table 160. BVI Description and Major Businesses
Table 161. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 162. BVI Product
Table 163. BVI Recent Development
Table 164. LIMOR Corporation Information
Table 165. LIMOR Description and Major Businesses
Table 166. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 167. LIMOR Product
Table 168. LIMOR Recent Development
Table 169. ME VAC Corporation Information
Table 170. ME VAC Description and Major Businesses
Table 171. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 172. ME VAC Product
Table 173. ME VAC Recent Development
Table 174. Agrovet Corporation Information
Table 175. Agrovet Description and Major Businesses
Table 176. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 177. Agrovet Product
Table 178. Agrovet Recent Development
Table 179. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Regions (2021-2026) (K L)
Table 180. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 184. North America: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 186. Europe: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2021-2026) (K L)
Table 188. Asia Pacific: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 190. Latin America: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2021-2026) (K L)
Table 192. Middle East and Africa: Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 193. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 194. Key Challenges
Table 195. Market Risks
Table 196. Main Points Interviewed from Key Foot and Mouth Disease (FMD) Vaccines Players
Table 197. Foot and Mouth Disease (FMD) Vaccines Customers List
Table 198. Foot and Mouth Disease (FMD) Vaccines Distributors List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Picture
Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Emergency Vaccines Product Picture
Figure 4. Conventional Vaccines Product Pictu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs